日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.

对一系列患者来源的异种移植瘤和细胞系进行基因组分析,发现伊沙匹隆是一种对抗化疗耐药性骨肉瘤的有效药物

Manara Maria Cristina, Bruzzese Francesca, Formentini Laura, Landuzzi Lorena, Pazzaglia Laura, Laginestra Maria Antonella, Carrabotta Marianna, Roca Maria Serena, Iannelli Federica, Grumetti Laura, Addi Laura, Parra Alessandro, Cristalli Camilla, Pasello Michela, Bavelloni Alberto, Carreras Francesca, Ruzzi Francesca, Bianchi Giuseppe, Gambarotti Marco, Righi Alberto, Budillon Alfredo, Lollini Pier-Luigi, Scotlandi Katia

Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling

综合蛋白质组学和代谢组学分析揭示了丙戊酸加辛伐他汀联合治疗前列腺癌异种移植模型中的抗肿瘤作用的新见解,该作用与 YAP/TAZ 信号的下调有关

Federica Iannelli #, Rita Lombardi #, Susan Costantini, Maria Serena Roca, Laura Addi, Francesca Bruzzese, Elena Di Gennaro, Alfredo Budillon, Biagio Pucci

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer

通过蛋白质组学方法鉴定出 HSP90 是逆转卵巢癌铂耐药性的可用药物靶点

Rita Lombardi, Maura Sonego, Biagio Pucci, Laura Addi, Federica Iannelli, Francesca Capone, Luigi Alfano, Maria Serena Roca, Maria Rita Milone, Tania Moccia, Alice Costa, Elena Di Gennaro, Francesca Bruzzese, Gustavo Baldassarre, Alfredo Budillon

Novel pathways involved in cisplatin resistance identified by a proteomics approach in non-small-cell lung cancer cells

通过蛋白质组学方法鉴定非小细胞肺癌细胞中与顺铂耐药性相关的新途径

Maria Rita Milone, Rita Lombardi, Maria Serena Roca, Francesca Bruzzese, Laura Addi, Biagio Pucci, Alfredo Budillon